This is a pretty technical article but basically it says that you need to target both pathways (NOTCH and PI3K) at the same time to have a major effect. There are a few drugs approved for PI3K inhibition and a few experimental NOTCH inhibitors in clinical trials. These have to be tried in combination for GBM.